Cancer Research Cancer Research Funding Available  Genetics and Biology of Brain Cancer
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 52, 4090-4095, August 1, 1992]
© 1992 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Preisler, H. D.
Right arrow Articles by Bokari, S. A. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Preisler, H. D.
Right arrow Articles by Bokari, S. A. J.

Multiparameter Assessment of the Cell Cycle Effects of Bioactive and Cytotoxic Agents1

Harvey D. Preisler2, Venu Gopal, Shripad D. Banavali, Daniel Finke and Syed A. J. Bokari

University of Cincinnati Medical Center, Cincinnati, Ohio 45267-0508

This paper describes the use of the bromodeoxyuridine/propidium iodide method to assess the effects of bioactive and cytotoxic agents on the kinetic characteristics of acute myelogenous leukemia cells. By careful selection of gates, the following parameters can be measured simultaneously using only 50,000 cells: the proportion of cells in S-phase, the distribution of cells within the S-phase compartment, the relative rate of DNA synthesis, the relative distribution of S-phase times, the proportion of So cells, and the proportion of cells in G1 and G2/M. This method was used to demonstrate that while retinoic acid, {alpha}-interferon, and cytosine arabinoside may all "inhibit" DNA synthesis, the actual effects of these agents differ. Retinoic acid appears to arrest cells in G1 without affecting the rate of DNA synthesis, while {alpha}-interferon and cytosine arabinoside "inhibit" DNA synthesis by reducing the rate of synthesis per se.

1 This work was supported by National Cancer Institute Grant CA 41285.

2 To whom requests for reprints should be addressed, at University of Cincinnati Medical Center, 231 Bethesda Avenue, M.L. 508, Cincinnati, OH 45267-0508.

Received 1/ 2/92. Accepted 5/12/92.




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
G. Sajithlal, H. Huttunen, H. Rauvala, and G. Munch
Receptor for Advanced Glycation End Products Plays a More Important Role in Cellular Survival than in Neurite Outgrowth during Retinoic Acid-induced Differentiation of Neuroblastoma Cells
J. Biol. Chem., February 22, 2002; 277(9): 6888 - 6897.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1992 by the American Association for Cancer Research.